(Q41185417)

28 September 2017

1 reference

title

The infectious etiology of peptic ulcer disease. Diagnosis and implications for therapy (English)

1 reference

28 September 2017

Brooks MJ

1

1 reference

28 September 2017

Maxson CJ

series ordinal

2

1 reference

28 September 2017

Rubin W

series ordinal

3

1 reference

28 September 2017

publication date

1 September 1996

1 reference

Primary Care: Clinics in Office Practice

28 September 2017

published in

1 reference

28 September 2017

volume

23

1 reference

28 September 2017

issue

3

1 reference

28 September 2017

page(s)

443-454

1 reference

Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970340-7

7 January 2021

Role of Helicobacter pylori serology in evaluating treatment success

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970340-7

7 January 2021

Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970340-7

7 January 2021

Current status of Helicobacter pylori in peptic ulcer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970340-7

7 January 2021

Campylobacter pylori and Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970340-7

7 January 2021

Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970340-7

7 January 2021

Factors influencing the eradication of Helicobacter pylori with triple therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970340-7

7 January 2021

Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970340-7

7 January 2021

Helicobacter pylori increases gastric antral juxtamucosal pH

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970340-7

7 January 2021

Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970340-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970340-7

1 reference

7 January 2021

Antral Helicobacter pylori, hypergastrinaemia, and duodenal ulcers: effect of eradicating the organism

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970340-7

7 January 2021

Eradication of Helicobacter pylori and prevention of recurrence of duodenal ulcer: a randomized, double-blind, multi-centre trial of omeprazole with or without clarithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970340-7

7 January 2021

Helicobacter pylori infection and gastric lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970340-7

7 January 2021

Seroprevalence of Helicobacter pylori infections in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970340-7

7 January 2021

Medical Treatment of Peptic Ulcer Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970340-7

7 January 2021

Fundal atrophic gastritis as a risk factor for gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970340-7

7 January 2021

Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970340-7

7 January 2021

10.1016/S0095-4543(05)70340-7

Identifiers

DOI

1 reference

28 September 2017

1 reference